Fulgent Genetics (MEX:FLGT) Interest Expense : MXN0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Fulgent Genetics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Fulgent Genetics's interest expense for the three months ended in Mar. 2024 was MXN 0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was MXN0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Fulgent Genetics's Operating Income for the three months ended in Mar. 2024 was MXN -362 Mil. Fulgent Genetics's Interest Expense for the three months ended in Mar. 2024 was MXN 0 Mil. GuruFocus does not calculate Fulgent Genetics's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fulgent Genetics Interest Expense Historical Data

The historical data trend for Fulgent Genetics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fulgent Genetics Interest Expense Chart

Fulgent Genetics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

Fulgent Genetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-	-	-	-

Fulgent Genetics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0 Mil.

Fulgent Genetics (MEX:FLGT) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Fulgent Genetics's Interest Expense for the three months ended in Mar. 2024 was MXN0 Mil. Its Operating Income for the three months ended in Mar. 2024 was MXN-362 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was MXN151 Mil.

Fulgent Genetics's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

GuruFocus does not calculate Fulgent Genetics's interest coverage with the available data.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Fulgent Genetics Inc has enough cash to cover all of its debt. Its financial situation is stable.

Fulgent Genetics (MEX:FLGT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Fulgent Genetics Inc (MEX:FLGT) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

FLGT:USA 7F0:Germany

Address

4978 Santa Anita Avenue, Temple City, CA, USA, 91780

Website

https://www.fulgentgenetics.com

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. Genetic testing offers the possibility of early identification of a disease or a genetic predisposition to disease and enhanced disease treatment and prognosis. Fulgent's product portfolio includes Genes & Panels, Known Mutation, Genomic Testing, Hereditary Cancer, Carrier Screening, Tumor Profiling, and Sequencing Service. Its customers are categorized as Insurance; Institutional, which includes hospitals, medical institutions, laboratories, governmental bodies, municipalities, and large corporations; and Patients. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.